Correction: A Comparative, Single-Blind, Randomized Study on Quetiapine and Aripiperazole Augmentation in Treatment of Selective Serotonin Reuptake Inhibitor Refractory Obsessive-Compulsive Disorder (Can. J. Physiol. Pharmacol., (2020) 98(4), (236-242), 10.1139/Cjpp-2019-0381)

Correction: A Comparative, Single-Blind, Randomized Study on Quetiapine and Aripiperazole Augmentation in Treatment of Selective Serotonin Reuptake Inhibitor Refractory Obsessive-Compulsive Disorder (Can. J. Physiol. Pharmacol., (2020) 98(4), (236-242), 10.1139/Cjpp-2019-0381) Publisher Pubmed

Talaei A^{1, 2} ; Hosseini FF^{1, 2} ; Aghili Z¹ ; Akhondzadeh S³ ; Asadpour E⁴ ; Mehramiz NJ⁵ ; Forouzanfar F^{6, 7}

Source: Canadian Journal of Physiology and Pharmacology Published:2020

Abstract

On p. 236, the affiliation line for A. Talaei and F.F. Hosseini is incorrect and should read as follows: Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Psychiatry, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. © 2020, Canadian Science Publishing. All rights reserved.

2. Erratum: How Mindfulness and Acceptance Could Help Psychiatrists Predict Alexithymia Among Students (The Journal of Nervous and Mental Disease (2021) 209 (297-301) Doi: 10.1097/Nmd.0000000000001295), Journal of Nervous and Mental Disease (2021)

Experts (# of related papers)

Ladan Kashani (1)

Shahin Akhondzadeh Basti (1)

Style	Citing Format
MLA	Talaei A, et al.. "Correction: A Comparative, Single-Blind, Randomized Study on Quetiapine and Aripiperazole Augmentation in Treatment of Selective Serotonin Reuptake Inhibitor Refractory Obsessive-Compulsive Disorder (Can. J. Physiol. Pharmacol., (2020) 98(4), (236-242), 10.1139/Cjpp-2019-0381)." Canadian Journal of Physiology and Pharmacology, vol. 98, no. 6, 2020, pp. 412-.
APA	Talaei A, Hosseini FF, Aghili Z, Akhondzadeh S, Asadpour E, Mehramiz NJ, Forouzanfar F (2020). Correction: A Comparative, Single-Blind, Randomized Study on Quetiapine and Aripiperazole Augmentation in Treatment of Selective Serotonin Reuptake Inhibitor Refractory Obsessive-Compulsive Disorder (Can. J. Physiol. Pharmacol., (2020) 98(4), (236-242), 10.1139/Cjpp-2019-0381). Canadian Journal of Physiology and Pharmacology, 98(6), 412-.
Chicago	Talaei A, Hosseini FF, Aghili Z, Akhondzadeh S, Asadpour E, Mehramiz NJ, Forouzanfar F. "Correction: A Comparative, Single-Blind, Randomized Study on Quetiapine and Aripiperazole Augmentation in Treatment of Selective Serotonin Reuptake Inhibitor Refractory Obsessive-Compulsive Disorder (Can. J. Physiol. Pharmacol., (2020) 98(4), (236-242), 10.1139/Cjpp-2019-0381)." Canadian Journal of Physiology and Pharmacology 98, no. 6 (2020): 412-.
Harvard	Talaei A et al. (2020) 'Correction: A Comparative, Single-Blind, Randomized Study on Quetiapine and Aripiperazole Augmentation in Treatment of Selective Serotonin Reuptake Inhibitor Refractory Obsessive-Compulsive Disorder (Can. J. Physiol. Pharmacol., (2020) 98(4), (236-242), 10.1139/Cjpp-2019-0381)', Canadian Journal of Physiology and Pharmacology, 98(6), pp. 412-.
Vancouver	Talaei A, Hosseini FF, Aghili Z, Akhondzadeh S, Asadpour E, Mehramiz NJ, et al.. Correction: A Comparative, Single-Blind, Randomized Study on Quetiapine and Aripiperazole Augmentation in Treatment of Selective Serotonin Reuptake Inhibitor Refractory Obsessive-Compulsive Disorder (Can. J. Physiol. Pharmacol., (2020) 98(4), (236-242), 10.1139/Cjpp-2019-0381). Canadian Journal of Physiology and Pharmacology. 2020;98(6):412-.
BibTex	@article{ author = {Talaei A and Hosseini FF and Aghili Z and Akhondzadeh S and Asadpour E and Mehramiz NJ and Forouzanfar F}, title = {Correction: A Comparative, Single-Blind, Randomized Study on Quetiapine and Aripiperazole Augmentation in Treatment of Selective Serotonin Reuptake Inhibitor Refractory Obsessive-Compulsive Disorder (Can. J. Physiol. Pharmacol., (2020) 98(4), (236-242), 10.1139/Cjpp-2019-0381)}, journal = {Canadian Journal of Physiology and Pharmacology}, volume = {98}, number = {6}, pages = {412-}, year = {2020} }
RIS	TY - JOUR AU - Talaei A AU - Hosseini FF AU - Aghili Z AU - Akhondzadeh S AU - Asadpour E AU - Mehramiz NJ AU - Forouzanfar F TI - Correction: A Comparative, Single-Blind, Randomized Study on Quetiapine and Aripiperazole Augmentation in Treatment of Selective Serotonin Reuptake Inhibitor Refractory Obsessive-Compulsive Disorder (Can. J. Physiol. Pharmacol., (2020) 98(4), (236-242), 10.1139/Cjpp-2019-0381) JO - Canadian Journal of Physiology and Pharmacology VL - 98 IS - 6 SP - 412 EP - PY - 2020 ER -

Style

Citing Format

MLA

Talaei A, et al.. "Correction: A Comparative, Single-Blind, Randomized Study on Quetiapine and Aripiperazole Augmentation in Treatment of Selective Serotonin Reuptake Inhibitor Refractory Obsessive-Compulsive Disorder (Can. J. Physiol. Pharmacol., (2020) 98(4), (236-242), 10.1139/Cjpp-2019-0381)." Canadian Journal of Physiology and Pharmacology, vol. 98, no. 6, 2020, pp. 412-.

APA

Talaei A, Hosseini FF, Aghili Z, Akhondzadeh S, Asadpour E, Mehramiz NJ, Forouzanfar F (2020). Correction: A Comparative, Single-Blind, Randomized Study on Quetiapine and Aripiperazole Augmentation in Treatment of Selective Serotonin Reuptake Inhibitor Refractory Obsessive-Compulsive Disorder (Can. J. Physiol. Pharmacol., (2020) 98(4), (236-242), 10.1139/Cjpp-2019-0381). Canadian Journal of Physiology and Pharmacology, 98(6), 412-.

Chicago

Talaei A, Hosseini FF, Aghili Z, Akhondzadeh S, Asadpour E, Mehramiz NJ, Forouzanfar F. "Correction: A Comparative, Single-Blind, Randomized Study on Quetiapine and Aripiperazole Augmentation in Treatment of Selective Serotonin Reuptake Inhibitor Refractory Obsessive-Compulsive Disorder (Can. J. Physiol. Pharmacol., (2020) 98(4), (236-242), 10.1139/Cjpp-2019-0381)." Canadian Journal of Physiology and Pharmacology 98, no. 6 (2020): 412-.

Harvard

Talaei A et al. (2020) 'Correction: A Comparative, Single-Blind, Randomized Study on Quetiapine and Aripiperazole Augmentation in Treatment of Selective Serotonin Reuptake Inhibitor Refractory Obsessive-Compulsive Disorder (Can. J. Physiol. Pharmacol., (2020) 98(4), (236-242), 10.1139/Cjpp-2019-0381)', Canadian Journal of Physiology and Pharmacology, 98(6), pp. 412-.

Vancouver

Talaei A, Hosseini FF, Aghili Z, Akhondzadeh S, Asadpour E, Mehramiz NJ, et al.. Correction: A Comparative, Single-Blind, Randomized Study on Quetiapine and Aripiperazole Augmentation in Treatment of Selective Serotonin Reuptake Inhibitor Refractory Obsessive-Compulsive Disorder (Can. J. Physiol. Pharmacol., (2020) 98(4), (236-242), 10.1139/Cjpp-2019-0381). Canadian Journal of Physiology and Pharmacology. 2020;98(6):412-.

BibTex

@article{ author = {Talaei A and Hosseini FF and Aghili Z and Akhondzadeh S and Asadpour E and Mehramiz NJ and Forouzanfar F}, title = {Correction: A Comparative, Single-Blind, Randomized Study on Quetiapine and Aripiperazole Augmentation in Treatment of Selective Serotonin Reuptake Inhibitor Refractory Obsessive-Compulsive Disorder (Can. J. Physiol. Pharmacol., (2020) 98(4), (236-242), 10.1139/Cjpp-2019-0381)}, journal = {Canadian Journal of Physiology and Pharmacology}, volume = {98}, number = {6}, pages = {412-}, year = {2020} }

RIS

TY - JOUR
AU - Talaei A
AU - Hosseini FF
AU - Aghili Z
AU - Akhondzadeh S
AU - Asadpour E
AU - Mehramiz NJ
AU - Forouzanfar F
TI - Correction: A Comparative, Single-Blind, Randomized Study on Quetiapine and Aripiperazole Augmentation in Treatment of Selective Serotonin Reuptake Inhibitor Refractory Obsessive-Compulsive Disorder (Can. J. Physiol. Pharmacol., (2020) 98(4), (236-242), 10.1139/Cjpp-2019-0381)
JO - Canadian Journal of Physiology and Pharmacology
VL - 98
IS - 6
SP - 412
EP -
PY - 2020
ER -

Science Communicator Platform

Authors

Abstract